DMAC:DiaMedica Therapeutics Inc Snapshot | Charting | News | Options
$3.17   0.00%  $0.00 NASDAQ 4:30p ET
May 8 '24 		DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results BusinessWire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on DMAC
    No News Available
    DiaMedica Therapeutics to Report First Quarter 2024 Financial Results...
    8:55a ET May 2 '24 BusinessWire
    DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of i...
    4:08p ET April 17 '24 BusinessWire
    DiaMedica Therapeutics Provides a Business Update and Announces Full ...
    4:15p ET March 19 '24 BusinessWire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.